Abbott Korea’s returned goods policy sparks criticism

Published: 2010-10-25 07:00:00

Updated: 2010-10-25 07:00:00

After Abbott Korea having expressed its intention to withdraw Reductil (sibutramine), a weight loss pill, from the local market, concerns have risen over its insincere policy of the corresponding returned goods.

In a returned-goods guideline issued to pharmacies and wholesalers, the company sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK